Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001584759-26-000009
Filing Date
2026-02-19
Accepted
2026-02-19 18:38:29
Documents
1
Period of Report
2026-02-17

Document Format Files

Seq Description Document Type Size
1 form4-02192026_110223.html 4  
1 form4-02192026_110223.xml 4 5723
  Complete submission text file 0001584759-26-000009.txt   7174
Mailing Address 264 TORREY PINES TERRACE DEL MAR CA 92014
Business Address
Heyman Richard A. (Reporting) CIK: 0001584759 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 26656029

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)